Peru Periodic Safety Report Schedule: Tiered Cadence from Approval to Year 5

Regulatory information verified as of October 29, 2026

1. Key takeaways

Periodic Safety Reports for medical devices in Peru follow a three-tier declining cadence tied to the age of the approval: from the date of health registration approval, every 6 months for the first 2 years, then annually for the following 3 years, and every 5 years from year 6 onward. The cadence derives from the Reglamento para el Registro, Control y Vigilancia Sanitaria de Productos Farmacéuticos, Dispositivos Médicos y Productos Sanitarios, namely D.S. N° 016-2011-SA (published on 2011-07-27), with specific article numbers pending verification; the official publication prevails. The key to scheduling is that the count starts from the date of approval, not from the date of market launch: products registered but not yet shipped enter the clock all the same. Regulatory information verified as of October 29, 2026.

2. Legal basis

3. Expert insights

Insight 1 | The declining cadence reflects the falling information density of a mature product

The first 2 years after launch are the dense period of exposure to unknown risks, which is why a submission every 6 months gives the competent authority the chance to detect early signals. From years 3 to 5, accumulated data are sufficient to characterize the basic safety profile, so the frequency drops to annual. From year 6 the cycle becomes every 5 years, echoing the re-registration cycle — this tier is in fact tied to the 5-year validity of the health registration. Reading the three stages as older means looser is a misjudgment: if an older product generates a new signal in vigilance, the incident-level reporting duties still apply at 24 hours or 20 calendar days, unaffected by the lower periodic frequency.

Insight 2 | The clock starts on the approval date, creating the hidden risk of registration-triggered counting

Many manufacturers anchor the schedule to the first shipment date or the first sale date; in Peru this is wrong. The mechanism starts from the premise that approval grants the product a lawful market position and activates the vigilance duties with it. A registered product that is not shipped for a long period still accumulates missed reporting periods, and a later inspection would require a one-time supplementation of multiple historical reports. The first step of our entry audits is always to pull the approval date and re-sequence every due date.

Insight 3 | The report is not a running log but a benefit-risk judgment with conclusions

The core value of a periodic safety report lies in whether the accumulated data change the existing conclusions. A report that merely lists complaint counts is worth less than one that delivers trend analysis, signal assessment, and a conclusion on whether the labeling or the Instructions for Use (Instrucciones de Uso) need updating. Where the report concludes that a label or labeling change is needed, it links into the change procedures of D.S. N° 016-2011-SA — this report-triggered change scenario is the one most often missed, because teams tend to treat vigilance and change control as unrelated processes.

4. Practical recommendations

1. Anchor the reporting calendar on the approval date for every registered product, including items not yet shipped.
2. Reserve internal drafting and internal QA review time before each due date to avoid last-minute compression, and mark public holidays in the calendar.
3. Fix the report structure in three sections: summary of accumulated data, trend and signal assessment, and conclusions on whether changes or corrective actions are triggered.
4. The moment a report conclusion points to a label, labeling or design change, transfer it immediately into the change procedure assessment; do not leave it for the next report.
5. Cross-check the incident ledger against the periodic reports so that the same signal is neither double-counted nor missed across the two lines.
6. During preparation of the re-registration (Reinscripción) dossier, retrieve all historical periodic reports and confirm that the reporting timeline is continuous, with no gaps.

5. Verification checklist

□ The applicable tier for this report has been confirmed: first 2 years (every 6 months), years 3 to 5 (annually), or from year 6 (every 5 years) (regulatory information verified as of October 29, 2026).

□ The starting point has been set at the approval date of the health registration, not the shipping or sales date.

□ All historical due dates have been inventoried with no missed reporting gaps; any gaps identified carry a written catch-up plan.

□ The report contains the three-section structure: accumulated data summary, signal assessment and explicit conclusions.

□ Any linkage items of the type report conclusion triggers label, labeling or design change have been identified.

□ The cadence is cited as D.S. N° 016-2011-SA, marked with specific article numbers pending verification; the official publication prevails.

□ The ledgers of periodic reporting and incident reporting (24 hours / 20 calendar days) are maintained separately, neither substituting the other, and both are archived.

Regulatory information verified as of October 29, 2026.

GRZAN provides medical device registration and post-market compliance support in Peru for manufacturers, importers and authorized representatives. For assistance, contact info@grzanglobal.com.